- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Osteoporosis
- Meeting Date: July 2025
- Public Summary Document (PSD) July 2025 PBAC Meeting - (PDF)
- Public Summary Document (PSD) July 2025 PBAC Meeting - (Word)
Teriparatide – July 2025
Teriparatide; Injection 250 micrograms per mL, 2.4 mL in multi-dose pre-filled pen; Ritosa
Last updated
9 July 2025